IIM
TNGX icon

INTECH Investment Management’s Tango Therapeutics TNGX Stock Holding History

INTECH Investment Management’s Portfolio TNGX Stock Details TNGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$794K Sell
37,959
-982
-3% -$13.7K 0.01% 1107
2025
Q4 		$345K Buy
38,941
+10,789
+38% +$93K ﹤0.01% 1683
2025
Q3 		$236K Sell
28,152
-17,523
-38% -$119K ﹤0.01% 1966
2025
Q2 		$234K Buy
45,675
+5,518
+14% +$13.6K ﹤0.01% 2009
2025
Q1 		$55K Buy
40,157
+12,238
+44% +$30.1K ﹤0.01% 2420
2024
Q4 		$86.3K Sell
27,919
-2,991
-10% -$13.9K ﹤0.01% 2241
2024
Q3 		$238K Buy
+30,910
New +$295K ﹤0.01% 1641

Other funds holding TNGX

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $762M AUM 1,125.36% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
TGI
TRV GP IV Boston, Massachusetts $267M AUM 965.83% 1-Year Est. Return

INTECH Investment Management's TNGX Position: Q1 2026 in Review

INTECH Investment Management reduced its Tango Therapeutics (TNGX) stake by 2.5% in Q1 2026, selling an estimated $13.7K and leaving 37,959 shares worth $794K. The position accounts for 0.01% of the portfolio, ranked #1107.

INTECH Investment Management first reported a position in TNGX in Q3 2024 and has held it in 7 quarters since. 194 funds tracked by Wall St. Rank hold TNGX as of Q1 2026.

  • INTECH Investment Management held 37,959 shares of Tango Therapeutics worth $794K as of Q1 2026.
  • INTECH Investment Management sold 982 Tango Therapeutics shares in Q1 2026, an estimated $13.7K.
  • Tango Therapeutics made up 0.01% of INTECH Investment Management's portfolio in Q1 2026, its #1107 holding.
  • INTECH Investment Management first reported a position in Tango Therapeutics in Q3 2024 and has held it in 7 quarters since.
  • 194 funds tracked by Wall St. Rank held Tango Therapeutics as of Q1 2026.

Based on INTECH Investment Management's 13F filing for Q1 2026, filed 8 May 2026.